Ranbaxy Laboratories Ltd. - Research Center
500359 RANBAXY Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 14 |
Jun ' 13 |
Dec ' 12 |
Jun ' 12 |
Dec ' 11 |
Sales |
3,487.31 |
2,820.52 |
2,911.17 |
3,392.37 |
5,312.78 |
Operating profit |
770.72 |
-118.90 |
143.59 |
316.90 |
986.52 |
Interest |
278.74 |
206.73 |
116.91 |
180.07 |
283.92 |
Gross profit |
537.76 |
-242.27 |
151.50 |
251.61 |
926.39 |
EPS (Rs) |
9.13 |
-12.73 |
-1.51 |
-2.33 |
-74.63 |
Half yearly
results in details
|
Sep ' 14 |
Jun ' 13 |
Dec ' 12 |
Jun ' 12 |
Dec ' 11 |
Other income |
45.78 |
83.37 |
124.82 |
114.78 |
223.79 |
Stock adjustment |
203.91 |
-25.06 |
-41.94 |
-7.31 |
17.41 |
Raw material |
616.67 |
810.22 |
785.61 |
751.16 |
902.62 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
534.41 |
508.88 |
514.79 |
504.80 |
410.65 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
1,361.61 |
1,645.39 |
1,509.12 |
1,826.83 |
2,995.58 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
125.80 |
89.94 |
90.75 |
95.41 |
180.84 |
Taxation |
9.24 |
- |
-1.94 |
- |
9.00 |
Net profit / loss |
386.87 |
-538.66 |
-63.90 |
-98.44 |
-3,149.52 |
Extra ordinary item |
-15.86 |
-206.46 |
-126.59 |
-254.64 |
-3,886.06 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
211.95 |
211.55 |
211.46 |
211.06 |
211.00 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
1493.14 |
1456.79 |
1452.39 |
1450.06 |
1458.28 |
Agg.of non promotoholding (%) |
35.22 |
34.43 |
34.34 |
34.35 |
34.56 |
OPM (%) |
22.10 |
-4.22 |
4.93 |
9.34 |
18.57 |
GPM (%) |
15.22 |
-8.34 |
4.99 |
7.17 |
16.73 |
NPM (%) |
10.95 |
-18.55 |
-2.10 |
-2.81 |
-56.89 |